Northern Trust
OLMA icon

Northern Trust’s Olema Pharmaceuticals OLMA Stock Holding History

Northern Trust’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.5M Buy
569,956
+124,629
+28% +$2.77M ﹤0.01% 2161
2025
Q4 		$11.1M Sell
445,327
-37,705
-8% -$671K ﹤0.01% 2024
2025
Q3 		$4.73M Sell
483,032
-16,392
-3% -$98.4K ﹤0.01% 2534
2025
Q2 		$2.13M Buy
499,424
+81,339
+19% +$363K ﹤0.01% 2945
2025
Q1 		$1.57M Sell
418,085
-5,702
-1% -$28.7K ﹤0.01% 3048
2024
Q4 		$2.47M Buy
423,787
+34,053
+9% +$340K ﹤0.01% 2904
2024
Q3 		$4.65M Buy
389,734
+45,652
+13% +$584K ﹤0.01% 2519
2024
Q2 		$3.72M Sell
344,082
-5,075
-1% -$55K ﹤0.01% 2557
2024
Q1 		$3.95M Sell
349,157
-3,661
-1% -$47.2K ﹤0.01% 2609
2023
Q4 		$4.95M Buy
352,818
+51,493
+17% +$692K ﹤0.01% 2525
2023
Q3 		$3.72M Buy
301,325
+6,569
+2% +$67K ﹤0.01% 2613
2023
Q2 		$2.66M Buy
294,756
+221,764
+304% +$1.34M ﹤0.01% 2842
2023
Q1 		$253K Buy
72,992
+5,374
+8% +$21.9K ﹤0.01% 3748
2022
Q4 		$166K Sell
67,618
-117
-0.2% -$341 ﹤0.01% 3946
2022
Q3 		$187K Buy
67,735
+7,535
+13% +$32K ﹤0.01% 3902
2022
Q2 		$245K Sell
60,200
-170,683
-74% -$541K ﹤0.01% 3816
2022
Q1 		$983K Sell
230,883
-20,225
-8% -$111K ﹤0.01% 3422
2021
Q4 		$2.35M Buy
251,108
+4,843
+2% +$100K ﹤0.01% 3145
2021
Q3 		$6.79M Buy
246,265
+112,823
+85% +$3.05M ﹤0.01% 2543
2021
Q2 		$3.73M Buy
133,442
+3,334
+3% +$94.9K ﹤0.01% 3011
2021
Q1 		$4.32M Buy
130,108
+116,206
+836% +$4.98M ﹤0.01% 2843
2020
Q4 		$668K Buy
+13,902
New +$652K ﹤0.01% 3645

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Northern Trust's OLMA Position: Q1 2026 in Review

Northern Trust increased its Olema Pharmaceuticals (OLMA) stake by 28% in Q1 2026, buying an estimated $2.77M and bringing the position to 569,956 shares worth $8.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2161.

Northern Trust first reported a position in OLMA in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.1M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Northern Trust held 569,956 shares of Olema Pharmaceuticals worth $8.5M as of Q1 2026.
  • Northern Trust bought 124,629 Olema Pharmaceuticals shares in Q1 2026, an estimated $2.77M.
  • Olema Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2161 holding.
  • Northern Trust first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Northern Trust's Olema Pharmaceuticals position peaked at $11.1M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.